4.8700
+0.2900
+(6.33%)
At close: April 15 at 4:00:00 PM EDT
4.7200
-0.15
(-3.08%)
After hours: April 15 at 7:57:11 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 175.76k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PINNOW COLE Officer | Purchase at price 7.60 per share. | Direct | 332,412 | Jan 14, 2025 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Director | -- | Indirect | -- | Jun 10, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 7.50 per share. | Indirect | 8,749,995 | Feb 16, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.00 per share. | Indirect | 9,600,000 | Jun 9, 2023 |
Related Tickers
BPMC Blueprint Medicines Corporation
81.45
-1.31%
APGE Apogee Therapeutics, Inc.
32.85
-1.29%
VRDN Viridian Therapeutics, Inc.
12.80
-3.76%
ATXS Astria Therapeutics, Inc.
4.1000
-2.84%
MLTX MoonLake Immunotherapeutics
36.77
+2.85%
CGEM Cullinan Therapeutics, Inc.
7.80
+0.78%
ELVN Enliven Therapeutics, Inc.
17.05
-0.81%
DNTH Dianthus Therapeutics, Inc.
19.21
+2.67%
SYRE Spyre Therapeutics, Inc.
12.71
-2.38%
NUVL Nuvalent, Inc.
70.78
+1.11%